RxDoctor Payments Data

Vince Scoggins, PA

Physician Assistant · Forest City, NCNPI 1578514261

Payments from drug & device makers

$1,224in general payments, 2019–2025

Across 71 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$266
  • AbbVie$262
  • Lilly USA, LLC$121
  • AstraZeneca$94
  • GSK$84
  • Pfizer$73
  • plus $324 from 10 others

What the payments were for

  • Food & beverage$1,224100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,224 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$28,043
Medicare patients
152
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide87$138,243
OzempicSemaglutide62$90,782
EliquisApixaban79$77,936
JardianceEmpagliflozin67$58,463
XifaxanRifaximin13$41,689
XareltoRivaroxaban38$35,508
VraylarCariprazine Hcl18$28,160
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$26,525
FarxigaDapagliflozin Propanediol25$24,606
MounjaroTirzepatide19$23,711
LinzessLinaclotide22$21,456
Combivent RespimatIpratropium/Albuterol Sulfate30$19,139
Tresiba Flextouch U-100Insulin Degludec22$18,489
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$12,705
Topiramate ErTopiramate20$9,907

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$121$161,955106 claims
Novo NordiskOzempic$266$90,78262 claims
PfizerEliquis$73$77,93679 claims
AbbVieVraylar, Linzess$262$49,61640 claims
GSKTrelegy Ellipta, Anoro Ellipta$84$39,23055 claims
AstraZenecaFarxiga, Symbicort$94$27,88239 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Forest City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →